Education
About Us
Working with TipRanks
Follow Us
InMode (INMD)
NASDAQ:INMD
INMD Stock Chart & Stats
$14.26
-$1.18(-6.78%)
At close: 4:00 PM EST
$14.26
-$1.18(-6.78%)
Day’s Range― - ―
52-Week Range$13.14 - $19.78
Previous CloseN/A
Volume968.14K
Average Volume (3M)552.11K
Market Cap
$901.36M
Enterprise Value$424.92M
Total Cash (Recent Filing)$532.31M
Total Debt (Recent Filing)$5.59M
Price to Earnings (P/E)6.6
Beta1.03
Next Earnings
Feb 10, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding63,209,152
10 Day Avg. Volume703,514
30 Day Avg. Volume552,108
Financial Highlights & Ratios
PEG Ratio-2.16
Price to Book (P/B)1.88
Price to Sales (P/S)3.35
P/FCF Ratio10.03
Enterprise Value/Market Cap0.47
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda2.85
Forecast
1Y Price Target
$17.33Price Target Upside21.53% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consumables And U.S. Sales MixGrowth in consumable product sales together with a higher U.S. sales mix signals early demand recovery in lower-cost treatments and supports recurring revenue streams.
Management Guidance And ExecutionTighter annual guidance combined with quarterly revenue guidance modestly above consensus suggests management confidence in sales momentum and execution improvements.
Non-invasive Product StrategyOngoing investment in less-expensive non-invasive procedures and clinical wellness offerings targets recession-resistant market segments and can diversify the revenue base.
Bears Say
Flat Near-term Revenue OutlookNear-term guidance implying essentially flat year-over-year revenue highlights persistent demand challenges in the aesthetics market and limited visibility into top-line growth.
Macro And Geopolitical UncertaintyMacro headwinds and geopolitical risks, including tariff exposure and regional conflict concerns, increase uncertainty around international supply chains and demand recovery.
Margin Pressure And Profitability RiskGuidance pointing to slightly lower gross margins than prior expectations raises the risk of margin compression and weaker near-term profitability.
InMode News
INMD FAQ
What was InMode’s price range in the past 12 months?
InMode lowest stock price was $13.14 and its highest was $19.78 in the past 12 months.
What is InMode’s market cap?
InMode’s market cap is $901.36M.
When is InMode’s upcoming earnings report date?
InMode’s upcoming earnings report date is Feb 10, 2026 which is in 31 days.
How were InMode’s earnings last quarter?
InMode released its earnings results on Nov 05, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.355 by $0.025.
Is InMode overvalued?
According to Wall Street analysts InMode’s price is currently Undervalued.
Does InMode pay dividends?
InMode does not currently pay dividends.
What is InMode’s EPS estimate?
InMode’s EPS estimate is 0.42.
How many shares outstanding does InMode have?
InMode has 63,209,152 shares outstanding.
What happened to InMode’s price movement after its last earnings report?
InMode reported an EPS of $0.38 in its last earnings report, beating expectations of $0.355. Following the earnings report the stock price went down -0.684%.
Which hedge fund is a major shareholder of InMode?
Currently, no hedge funds are holding shares in INMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InMode Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.33 (21.53% Upside)
$17.33 (21.53% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 208.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.93%
12-Months-Change
Fundamentals
Return on Equity
21.52%
Trailing 12-Months
Asset Growth
-10.85%
Trailing 12-Months
Company Description
InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
INMD Company Deck
INMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call presented a mix of positive developments, such as international expansion and strong consumables growth, but these were overshadowed by significant declines in revenue, gross margins, operating margins, and net income compared to the previous year.View all INMD earnings summariesINMD Stock 12 Month Forecast
Average Price Target
$17.33
▲(21.53% Upside)
Technical Analysis
Orthofix
―
AxoGen
―
Establishment Labs Holdings
―
SS Innovations International
―
Bioventus
―
Ownership Overview
―
Insiders
5.79% Mutual Funds
24.92% Other Institutional Investors
66.21% Public Companies and
Individual Investors